COPENHAGEN - Danish drugmaker Novo Nordisk will launch its weight-loss drug Wegovy in India without any supply constraints, a company spokesperson said on Tuesday.

"We are committed to addressing the unmet needs of patients living with chronic diseases such as obesity, thus this will be a full launch," the spokesperson said in an emailed statement.

"We do not anticipate any supply constraints and are confident of stable supply of the product in India."